v3.26.3
Summary of Significant Accounting Policies (Tables)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Accounting Policies [Abstract]    
Schedule of Disaggregated Revenue by Timing of Revenue Recognition

The following table provides information about disaggregated revenue from continuing operations by timing of revenue recognition:

 

   For the three months ended   For the six months ended 
   June 30,   June 30,   June 30,   June 30, 
   2026   2025   2026   2025 
Timing of revenue recognition                
Products and services transferred over time  $-   $-   $-   $- 
Products and services transferred at a point in time   1,561,884    1,055,191    3,441,177    2,252,805 
Total Revenue  $1,561,884   $1,055,191   $3,441,177   $2,252,805 

The following table provides information about disaggregated revenue by timing of revenue recognition:

 

   December 31,   December 31, 
   2025   2024 
Timing of revenue recognition        
Products and services transferred over time  $4,272,832   $5,129,440 
Products and services transferred at a point in time   10,345,352    5,291,912 
Total Revenue  $14,618,184   $10,421,352 
Schedule of Basic and Diluted Earnings Per Share Attributable to Continuing Operations

The following table presents basic and diluted earnings per share attributable to continuing operations for the three and six months ended June 30, 2026, and 2025.

 

   Three months ended   Six months ended 
   June 30,
2026		   June 30,
2025		   June 30,
2026		   June 30,
2025		 
Net loss from continuing operations - basic and diluted, net of tax  $(3,080,442)  $(1,903,933)  $(4,344,228)  $(5,543,067)
Weighted average shares outstanding – basic and diluted   670,722    205,283    641,004    204,603 
Net loss per share from continuing operations – basic and diluted  $(4.59)  $(9.27)  $(6.78)  $(27.09)
Excluded securities: (1)                    
Public Warrants   123,468    143,750    123,468    143,750 
Private Warrants   6,963    6,963    6,963    6,963 
Bridge Warrants   2,174    2,174    2,174    2,174 
Extension Warrants   326    326    326    326 
September 2024 Warrants   9,259    9,259    9,259    9,259 
Quantum Convertible Note, related party (2)   -    23,281    -    23,281 
Exchange Note (2)   -    10,342    -    10,342 
September 2024 Convertible Note (3)   -    15,734    -    15,734 
Series A Preferred stock common stock equivalents (4)   761    38,488    761    38,488 
Stock options granted   10,046    10,046    10,046    10,046 
Common stock issuance obligation   640    640    640    640 
March 2025 Convertible Note (5)   -    771    -    437 
May 2025 Convertible Note (6)   -    845    -    423 
Common Stock Warrants   245,902    -    245,902    - 
ClearThink Convertible Note (7)   25,128    -    17,475    - 

 

(1)The Company’s diluted shares have not been included in the computation of diluted net loss per share from continuing operations for the three and six months ended June 30, 2026, and 2025, as the result would be anti-dilutive.
  (2) Includes the interest amount thereon and assumes the floor conversion price of $160.00.

 

  (3) Includes the principal and interest amount thereon and calculated based on the initial fixed conversion price of $160.00.

 

  (4) Assumes the maximum conversion thereon at the floor conversion price of $160.00.

 

  (5) Includes the interest amount thereon and assumes the floor conversion price of $160.00.

 

(6)Includes the interest amount thereon and assumes the closing price as of the reporting date.

 

(7)Includes the interest amount thereon and assumes the average closing price for the reporting period.
   Three months ended   Six months ended 
   June 30,
2026		   June 30,
2025		   June 30,
2026		   June 30,
2025		 
Net income (loss) from discontinued operations - basic  $3,927,715   $(709,350)  $2,591,239   $(1,029,656)
Weighted average shares outstanding – basic   670,722    205,283    641,004    204,603 
Net income (loss) per share from discontinued operations – basic  $5.86   $(3.46)  $4.04   $(5.03)
                     
Net income (loss) from discontinued operations - diluted   3,920,835    (709,350)   2,578,216    (1,029,656)
Weighted average shares outstanding – diluted   697,250    205,283    659,879    204,603 
Net income (loss) per share from discontinued operations – diluted  $5.62   $(3.46)  $3.91   $(5.03)
Excluded securities: (1)                    
Public Warrants   123,468    143,750    123,468    143,750 
Private Warrants   6,963    6,963    6,963    6,963 
Bridge Warrants   2,174    2,174    2,174    2,174 
Extension Warrants   326    326    326    326 
September 2024 Warrants   9,259    9,259    9,259    9,259 
Quantum Convertible Note, related party (2)   -    23,281    -    23,281 
Exchange Note (2)   -    10,342    -    10,342 
September 2024 Convertible Note (3)   -    15,734    -    15,734 
Series A Preferred stock common stock equivalents (4)   -    38,488    -    38,488 
Stock options granted   10,046    10,046    10,046    10,046 
Common stock issuance obligation   -    640    -    640 
March 2025 Convertible Note (5)   -    771    -    437 
May 2025 Convertible Note (6)   -    845    -    423 
Common Stock Warrants   245,902    -    245,902    - 

  

(1)The Company’s diluted shares have not been included in the computation of diluted net loss per share from discontinued operations for the three and six months ended June 30, 2025, as the result would be anti-dilutive.

 

  (2) Includes the interest amount thereon and assumes the floor conversion price of $160.00.

 

  (3) Includes the principal and interest amount thereon and calculated based on the initial fixed conversion price of $160.00.

 

  (4) Assumes the maximum conversion thereon at the floor conversion price of $160.00.

 

  (5) Includes the interest amount thereon and assumes the floor conversion price of $160.00.

 

(6)Includes the interest amount thereon and assumes the closing price as of the reporting date.
   Year Ended December 31, 
   2025   2024 
         
Net loss  $(14,712,850)  $(57,702,015)
Weighted average shares outstanding – basic and diluted   251,792    127,663 
Net loss per share – basic and diluted  $(58.43)  $(451.99)
Excluded securities:(1)          
Public Warrants   123,468    143,750 
Private Warrants   6,963    6,963 
Bridge Warrants   2,174    2,174 
Extension Warrants   326    326 
September 2024 Warrants   9,259    9,259 
Common Stock Warrants   245,902    - 
Quantum Convertible Note, related party (2)   2,587    23,281 
Exchange Note (3)   -    10,342 
September 2024 Convertible Note (3)   -    15,734 
Series A Preferred stock common stock equivalents (4)   11,175    38,488 
Stock options granted   10,046    10,046 
Common stock issuance obligation   640    640 

 

(1)The Company’s dilutive shares have not been included in the computation of diluted net loss per share for the years ended December 31, 2025 and 2024, as the result would be anti-dilutive.

 

(2) Includes the interest amount thereon and assumes the floor conversion price of $160.00, was partially converted during the year in 2025.

  

(3)Fully converted during the year 2025.

 

(4) Assumes the maximum conversion thereon and at the floor conversion price of $160.00, partially converted during the year 2025.
Schedule of Allowance for Credit Losses

The following table presents the Company’s allowance for credit losses on June 30, 2026, and December 31, 2025:

 

   June 30,
2026		   December 31,
2025		 
         
Beginning allowance for credit losses  $835,007   $2,393,033 
Add: Credit loss expense   872,122    1,029,317 
Less: Accounts receivable write-off included in allowance for credit losses above   (64,895)   (2,587,343)
Ending allowance for credit losses  $1,642,234   $835,007 
   December 31,   December 31, 
   2025   2024 
Beginning allowance for credit losses  $2,393,033   $32,457 
Add: Allowance for credit losses, due to acquisition   —    1,696,553 
Add: Provision for credit losses   1,029,317    514,282 
(Less)/Add: Accounts receivable write-off included in allowance for credit losses above   (2,587,343)   149,741 
Ending allowance for credit losses  $835,007   $2,393,033 
Schedule of Identifiable Intangible Assets Subject to Amortization Developed technology and customer relationships are amortized using the straight-line method over the five-year and ten-year estimated useful lives of the assets, respectively.
   Estimated  June 30,   December 31, 
   Useful Life  2026   2025 
Customer relationships  10 years  $2,100,000   $2,100,000 
Developed technology  5 years   10,000,000    10,000,000 
Accumulated amortization      (4,419,996)   (3,315,000)
Intangible assets, net     $7,680,004   $8,785,000 
   Estimated  December 31,   December 31, 
   Useful Life  2025   2024 
Customer relationships  10 years  $2,100,000   $2,100,000 
Developed technology  5 years   10,000,000    10,000,000 
Accumulated amortization      (3,315,000)   (1,105,000)
Intangible assets, net     $8,785,000   $10,995,000 
Schedule of Expected Amortization Expense

Expected amortization expense is as follows:

 

Year ending December 31, 2026 (remaining six months)  $1,105,004 
Year ending December 31, 2027   2,210,000 
Year ending December 31, 2028   2,210,000 
Year ending December 31, 2029   1,210,000 
Year ending December 31, 2030   210,000 
Thereafter   735,000 
Total  $7,680,004 
Year ending December 31, 2026  $2,210,000 
Year ending December 31, 2027   2,210,000 
Year ending December 31, 2028   2,210,000 
Year ending December 31, 2029   1,210,000 
Year ending December 31, 2030   210,000 
Thereafter   735,000 
Total  $8,785,000 
Schedule of Deferred Revenue Activities  
   December 31,   December 31, 
   2025   2024 
Beginning of year  $487,814   $902,524 
Additions   2,431,300    1,519,617 
Revenue recognized   (1,594,629)   (1,934,327)
End of year  $1,324,485   $487,814 
Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets  
   Estimated Useful Life
Office equipment  3-5 years
Medical equipment  3-10 years
Furniture  3-7 years
Leased equipment  Shorter of lease term or estimated useful life
Leasehold improvements  3-7 years